Benzinga | Nov 22, 2021 07:08AM EST

Amicus Therapeutics Announces Presentations At The 14th International Congress Of Inborn Errors Of Metabolism

Amicus Therapeutics (NASDAQ:FOLD), today announced two digital posters for presentation at the 14th International Congress of Inborn Errors of Metabolism (ICIEM) being held virtually and in Sydney, Australia, November 21-23, 2021.



Digital Poster Presentations:

* Long-term multisystemic efficacy with migalastat in ERT-na?ve and ERT-experienced patients with amenable GLA variants Presenter: Drago Bratkovic, MD, PARC Research Clinic, Adelaide, Australia

* Incidence and prevalence of newborn, paediatric, and adolescent patients with Fabry disease: a targeted literature review Presenter: Ian Keyzor, Amicus Therapeutics, Marlow, United Kingdom

The posters can be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com.

For more information on the International Congress of Inborn Errors of Metabolism 2021, please visit www.iciem2021.com.au.